Studies on pharmacological enhancement of blood fibrinolytic activity.
D000368:Aged; D001161:Arteriosclerosis / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D002994:Clofibrate / Q000627:therapeutic use; D005260:Female; D005340:Fibrinogen / Q000378:metabolism; D005342:Fibrinolysis / Q000187:drug effects*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D005779:Immunodiffusion; D008297:Male; D008687:Metformin / Q000627:therapeutic use; D008875:Middle Aged; D010958:Plasminogen / Q000378:metabolism; D012712:Serum Globulins; D013268:Stimulation, Chemical; D013739:Testosterone / Q000627:therapeutic use; D013927:Thrombosis / Q000517:prevention & control; D014042:Tolazamide / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D012712:Serum Globulins; D013739:Testosterone; D005340:Fibrinogen; D010958:Plasminogen; D008687:Metformin; D014042:Tolazamide; D002994:Clofibrate